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Abstract
Background: We examined marijuana and alcohol use trends among drivers aged ≥16 years 
evaluated at Level I trauma centers before and after Arizona legalized medical marijuana in April 
2011.
Methods: We conducted interrupted time series (ITS) analysis of urine drug screens for 
marijuana metabolites and blood alcohol concentration (BAC) data from the 2008–2014 Arizona 
State Trauma Registry.
Results: Among 30,083 injured drivers, 14,710 had marijuana test results, and 2590 were 
positive for marijuana; of these, 1087 (42%) also tested positive for alcohol. Among 23,186 
drivers with BAC results, 5266 exceeded the legal limit for their age. Compared with prelaw trends 
(models if law had not been enacted), postlaw models showed small but significant annual 
increases in the proportions of drivers testing positive for either substance. By the end of 2014, the 
proportion of drivers testing positive for marijuana was 9.6% versus a projected 5.6% if the law 
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had not been enacted, and the proportion of drivers with illegal BACs was 15.7% versus a 
projected 8.2%. When ITS was restricted to only substance-tested drivers, no significant 
differences were detected.
Conclusions: Despite the small annual postlaw increases in the proportion of marijuana-positive 
drivers compared with the prelaw trend, alcohol-impaired driving remains a more prevalent threat 
to road safety in Arizona.
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1. Introduction
As of March 2019, ten states and Washington DC had legalized marijuana for medical and 
recreational use and 22 states for only medical use. Arizona, the state of interest in this 
study, has legalized marijuana for medical use only (Insurance Institute for Highway Safety, 
2019). On April 14, 2011, Arizona’s Medical Marijuana Program began issuing Medical 
Marijuana Registry Identification cards (Arizona Department of Health Services, 2014). To 
qualify for the program, patients with a debilitating medical condition must submit required 
documentation from a physician, licensed in Arizona, and must renew their registration 
annually. The total number of qualifying patients in the program increased from 17,852 in 
2011 to 61,272 in 2014 (Arizona Department of Health Services, 2014).
As more states have legalized marijuana use, there has also been an increase in public safety 
concerns related to impaired driving. Findings from the National Roadside Survey of 
Alcohol and Drug Use provide some justification for concerns. The proportion of weekend, 
nighttime drivers in the United States with any measurable amount of delta-9-
tetrahydrocannabinol (THC), the psychoactive component of marijuana, or its active 
metabolite 11-OH-THC, measured in oral fluid, increased from 8.6% in 2007 to 12.6% 
during 2013–2014 (Berning et al., 2013).
Unlike alcohol, increasing THC concentrations in biologic fluids do not consistently equate 
with increased driving impairment (Sewell et al., 2009), and studies of crash risk among 
THC-positive drivers have reported inconsistent results (Asbridge et al., 2014; Compton and 
Berning, 2015; Li et al., 2013; Romano et al., 2014). However, authors of a recent 
metaregression analysis of this literature concluded that marijuana use was associated with a 
low-to-moderate increase in crash risk (Rogeberg and Elvik, 2016). Also, studies examining 
driver error or crash risk among drivers who test positive for both marijuana and alcohol 
have consistently reported elevated risk compared with drivers testing positive for either 
substance alone (Downey et al., 2013; Dubois et al., 2015; Li et al., 2013; Sewell et al., 
2009). Under Arizona law, drivers who test positive for THC at any concentration can be 
charged with driving under the influence of marijuana (Ariz. Rev. Stat., 2016).
Rates of alcohol and other drug testing of drivers involved in motor vehicle crashes are 
highest for crashes that involve a fatality (fatal crash), and testing rates vary substantially 
across states (National Highway Transportation Safety Administration, 2018). In 2014 in 
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Arizona, 81% of the 417 fatally injured drivers and 30% of the 605 drivers who survived a 
fatal crash had alcohol test results recorded in the National Highway Traffic Safety 
Administration’s Fatality Analysis Reporting System (FARS) (National Highway 
Transportation Safety Administration, 2018). Testing rates for drugs other than alcohol 
(prescription or illicit; hereafter referred to as drugs) are lower. In 2014, approximately 78% 
of fatally injured drivers and only 8% of drivers who survived a fatal crash in Arizona had 
any drug test results recorded in FARS (National Highway Transportation Safety 
Administration, 2018). Even less is known about substance use among drivers involved in 
crashes in which no one is killed (nonfatal crashes). However, studies of persons injured in 
motor vehicle crashes have consistently reported alcohol and marijuana to be among the 
most commonly detected substances, and the two are often found in combination (Baldock 
and Lindsay, 2015; Brubacher et al., 2016; Walsh et al., 2005).
To more fully understand trends in marijuana and alcohol use among drivers injured in 
crashes before and after medical marijuana legalization, we examined Arizona State Trauma 
Registry (ASTR) data of drivers evaluated at any of the 10 Level I trauma centers in the state 
during 2008–2014. We described characteristics of drivers who tested positive for marijuana 
(THC), alcohol, and both marijuana and alcohol, and explored whether the proportion of 
drivers who tested positive for marijuana, alcohol, or the two substances combined changed 
post-legalization of medical marijuana.
2. Methods
ASTR receives data from trauma centers in Arizona, including all Level I trauma centers 
(L1TCs); eight of 10 L1TCs are located in the Phoenix Metropolitan Area, one in Tucson, 
and one in Flagstaff. ASTR contains data on patients triaged by emergency medical services 
(EMS) to trauma centers, patients with injuries transported from one hospital to another, or 
patients meeting other criteria, as defined in the ASTR inclusion criteria (Arizona 
Department of Health Services, 2016).
The decision to perform drug or alcohol testing at Arizona trauma centers is dependent on 
clinicians’ judgment; if the clinician does not suspect substance use, testing is less likely to 
be performed. In this study, drug testing is defined as a qualitative urine drug screen 
(positive or negative) used to detect substances by enzyme immunoassay. ASTR separately 
records positive results for detectable levels of THC, me-thamphetamines, barbiturates, 
benzodiazepines, cocaine, opioids, and phencyclidine. All other drugs are categorized as 
other drugs. ASTR also records quantitative blood alcohol concentration (BAC) test results 
in grams per deciliter (g/dL).
For these analyses, we included drivers of cars, trucks of all sizes, or vans, aged ≥16 years, 
evaluated at a L1TC for injuries sustained in a motor vehicle crash during 2008–2014. We 
examined age, sex, race/ethnicity, whether drug or alcohol tests were performed, and test 
results.
The number of L1TCs in Arizona increased from eight during 2008–2013 to 10 in 2014; 
both L1TCs added in 2014 were in the Phoenix Metropolitan Area. The increase in L1TCs 
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should not have substantially affected the number of injured drivers evaluated at L1TCs 
because EMS uses an established triage protocol based on injury severity when deciding 
whether to transport to a L1TC. For this study, we examined the proportion of drivers testing 
positive for marijuana, alcohol, or both marijuana and any detectable alcohol rather than 
total numbers. This approach helps account for the increase in L1TCs and unmeasured 
temporal trends that might have influenced crash risk (e.g., the economic recession and 
recovery or changes in travel patterns and traffic enforcement).
Because ATSR does not record whether an injured driver is an active patient in the Arizona 
Medical Marijuana Program, the annual number of Medical Marijuana Program qualifying 
patients for 2011–2014 was included in Table 1 to provide context to our analyses (Arizona 
Department of Health Services, 2014).
All statistical analyses were performed using SAS® version 9.3 (SAS Institute, Inc., Cary, 
North Carolina). We used interrupted time series analysis (Wagner et al., 2002) to assess 
whether significant changes occurred in the level and slope after the medical marijuana law 
was implemented in April 2011; we examined the monthly proportion of all drivers who had 
a positive urine drug screen for marijuana, BAC above the legal limit for their age (≥0.08 
g/dL for drivers aged ≥21 years and any conclusive level (BAC > 0g/dL) for drivers aged 
16–20 years), and marijuana with any detectable alcohol. Any detectable alcohol, as 
opposed to BAC above the legal limit, was used in combination with marijuana because 
alcohol and marijuana have synergistic effects on driver impairment (Downey et al., 2013; 
Dubois et al., 2015; Li et al., 2013; Sewell et al., 2009). We defined April 2011 as the 
segmentation point for time series analysis, because it was the first month medical marijuana 
patient registry cards were issued. Models were corrected for up to 12th order 
autocorrelation using a back-step automatic selection procedure. We calculated the 
difference in proportion of drivers with a positive urine screen for marijuana use, estimated 
from the model, including terms associated with the implementation of the law (i.e., level 
and slope) and from the model, including terms associated only with baseline level and 
secular trends. This difference estimates the proportion of drivers who would not have tested 
positive had the law not been implemented and was considered statistically significant at P < 
0.05. Confidence intervals for differences were calculated using the delta method reported 
previously (Zhang et al., 2009). The analysis was repeated for the outcomes of BAC above 
the legal limit and for marijuana with any detectable alcohol. We also repeated interrupted 
time series analyses, excluding untested drivers to observe whether trends in the proportion 
of drivers testing positive for drugs and alcohol were associated with trends in the proportion 
of drivers tested for drugs and alcohol.
This project was reviewed by the Centers for Disease Control and Prevention and 
determined to be exempt from human subjects regulations because we analyzed data without 
personal identifiers.
3. Results
During 2008–2014, 30,083 injured drivers aged ≥ 16 years involved in motor vehicle crashes 
who qualified for study inclusion were evaluated at Arizona L1TCs and reported in ASTR. 
Jones et al. Page 4
Drug Alcohol Depend. Author manuscript; available in PMC 2020 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Among injured drivers, 49% (n = 14,710) were tested for drugs, 77% (n = 23,186) were 
tested for alcohol, and 47% (n = 14,139) were tested for both drugs and alcohol (Table 1). 
Ninety-six percent of drivers tested for drugs were also tested for alcohol, and 61% of 
drivers tested for alcohol were also tested for drugs. The proportion of drivers tested for 
drugs varied by year, from 46% in 2010 to 54% in 2008 and 2013 (Table 1). The proportion 
of drivers tested for alcohol varied from 73% in 2009 to 82% in 2013.
Table 2 presents demographic characteristics of the total study population, number and 
proportion of injured drivers tested for drugs, alcohol, or both substances, and number and 
proportion of all drivers with positive test results. Certain differences in demographic 
characteristics were noted in the proportions of injured drivers who were tested. For 
example, for drugs, proportions tested varied by age from 54% among drivers aged 26–34 
years to 37% among drivers aged ≥ 65 years, and by racial groups from 62% for American 
Indians to 44% for Asians. Proportions of drivers tested for alcohol showed similar patterns. 
For example, alcohol testing among racial groups varied from 86% for American Indians to 
70% for Asians.
Overall, 9% of the 30,083 injured drivers tested positive for THC, 18% had BACs above the 
legal limit for their age, and 4% tested positive for both substances.
Among drivers with marijuana test results, age groups with the highest proportions testing 
positive were 16–20 years (29%, [597/2,074]) and 21–25 years (27%, [669/2,487]), 
declining to 2% among drivers aged ≥65 years (28/1,347). Racial groups with the highest 
proportions testing positive for marijuana among those tested were black (27%, [218/819]) 
and American Indian (23%, [277/1,201]). In addition, 18% (215/1,172) of American Indians 
who were tested for marijuana and alcohol had positive results for both substances, a 
proportion greater than twice that of other racial groups.
Of the 23,186 injured drivers tested for alcohol, 23% (n = 5266) had a BAC above the legal 
limit for their age; 80% (n = 4229) of these drivers had BACs ≥0.15g/dL (data not shown). 
Although any detectable alcohol is illegal for drivers aged < 21 years, 82% (n = 564) of 
injured drivers aged 16–20 years with positive BACs had BACs ≥ 0.08 g/dL, levels which 
are illegal for drivers aged ≥ 21 years (data not shown). Among the 14,710 injured drivers 
with marijuana test results, 2590 (18%) were positive for THC; of these, 1087 (42%) also 
tested positive for any alcohol. Among the 1087 drivers who tested positive for both 
marijuana and alcohol, 72% (n = 781) had BACs ≥ 0.15 g/dL (data not shown).
3.1. Analysis of trends among injured drivers testing positive for marijuana or alcohol
The interrupted time series analysis estimated that during January 2008–April 2011, the 
proportion of injured drivers testing positive for marijuana decreased by 0.5%/year (95% CI: 
−1.0/year, 0.0/year). After medical marijuana legalization in April 2011, a significant 
increase in the slope of the trend line (i.e., measure of change in trend) occurred, which 
yielded a postlaw increasing slope of 0.6%/year (95% CI: 0.0/year, 0.8/year). The prelaw to 
postlaw abrupt level increase (i.e., measure of immediate change) of 0.6% (95% CI: −0.7, 
1.9) was not significant (Fig. 1, Panel A). Based on the model, by December 2014 (study 
period end), the proportion of drivers that would test positive for marijuana was 9.6% versus 
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a projected 5.6% if the law had not been enacted, a difference of 4.0 percentage points (95% 
CI: 1.2, 6.9).
During January 2008–April 2011, there was a 1.9%/year decrease in the proportion of 
injured drivers testing positive for alcohol above the legal limit for their age (95% CI: −2.6/
year, −1.3/year). After the law was implemented in April 2011, a significant increase in the 
slope of the trend line occurred, which yielded a postlaw slope of −0.5%/year (95% CI: 
−1.0/year, 0.0/year). The prelaw to postlaw abrupt level increase of 2.2 percentage points 
(95% CI: 0.5, 3.6) was also statistically significant. The difference in the proportion of 
drivers testing positive for alcohol above the legal limit at the end of 2014 was 7.5 
percentage points (95% CI: 3.8, 11.1); 15.7% with the law versus a projected 8.2% if the law 
had not been enacted (Fig. 1, Panel B).
During January 2008–April 2011, there was a 0.5%/year decrease in the proportion of 
injured drivers testing positive for marijuana plus any alcohol (95% CI: −0.8/year, −0.2/
year). After the law was implemented, a significant increase in the slope of the trend line 
occurred, yielding a postlaw slope of 0.0 percentage points per year (95% CI: −0.3/year, 0.2/
year). The prelaw to postlaw abrupt level increase of 0.8 percentage points (95% CI: −0.1, 
1.5) was also statistically significant. The difference in the proportion of injured drivers 
testing positive for marijuana plus any alcohol at the end of 2014 was 2.5 percentage points 
(95% CI: 0.9, 4.0); 3.5% with the law versus a projected 1.0% if the law had not been 
enacted) (Fig. 1, Panel C).
When restricting the time series analyses to only injured drivers who were tested for drugs 
or alcohol (i.e., excluding those who were not tested), no significant differences were 
observed between the prelaw and postlaw slopes for marijuana, alcohol, or the two 
substances combined.
4. Discussion
In a population of injured drivers evaluated at Arizona L1TCs during 2008–2014, we found 
that 9% of all drivers and 18% of drivers tested for drugs tested positive for marijuana. 
These proportions are similar in magnitude to those from other recent studies of marijuana 
use among crash-involved, injured drivers in the United States (Walsh et al., 2005), Australia 
(Baldock and Lindsay, 2015), Canada (Brubacher et al., 2016), and Europe (Cittadini et al., 
2017). Likewise, we found that 18% of all drivers and 23% of drivers tested for alcohol had 
BACs above the legal limit for their age. Of note, among the drivers with BACs above the 
legal limit, 79% had BACs ≥0.15 g/dL, nearly twice the legal BAC limit for drivers aged ≥ 
21 years. In addition, among drivers who tested positive for marijuana and any alcohol, 72% 
had BACs >0.15 g/dL. At BACs ≥0.15g/dL, drivers aged 16–20 years are estimated to be 
approximately 500 times as likely to be involved in a fatal crash than their sober 
counterparts (i.e., BAC = 0 g/dL); for drivers aged ≥ 21 years, the risk for fatal crash 
involvement is approximately 100 times that of their sober counterparts (Voas et al., 2012). 
Any additional impairment from marijuana would likely increase their already excessive 
crash risk (Downey et al., 2013; Dubois et al., 2015; Li et al., 2013; Sewell et al., 2009).
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Interrupted time series analysis revealed a small but statistically significant annual increase 
in the proportion of all injured drivers who tested positive for marijuana after medical 
marijuana was legalized in Arizona compared with what would have been expected without 
legalization based on existing trends. However, this association is not equal to causation and 
might reflect the overall trend of the general U.S. population consuming more marijuana 
during 2008–2014 (Center for Behavioral Health Statistics and Quality, 2014). This 
association might also be partially explained by changes in testing after legalization, because 
no significant increase was reported when excluding those who were not tested for drugs. 
Information was not available regarding whether or not any of 10 L1TCs altered their drug 
testing practices in response to the medical marijuana law, although changes were unlikely 
because there were far more recreational marijuana users than medical marijuana card 
holders (Hughes et al., 2016). Additionally, health care providers are more likely to test for 
drugs when they suspect a patient was driving under the influence. Because there is a direct 
correlation between suspecting a patient was driving under the influence and ordering drug 
testing, including all drivers and not restricting to only drivers tested for drugs likely 
provides a more accurate representation of trends.
We also report small but significant annual postlaw increases in proportions of injured 
drivers that tested positive for alcohol above the legal limit and positive for both marijuana 
and any alcohol. Whether any of these increases are directly associated with marijuana 
legalization is unclear. Arizona experienced a 28% decrease in police-reported drug-
impaired or alcohol-impaired vehicle crashes resulting in serious injuries, from 888 in 2008 
to 643 in 2014 (Arizona Governor’s Office of Highway Safety, 2017). Additionally, 
impaired driving traffic enforcement increased markedly. Arrests for driving under the 
influence of drugs increased more than 500% from 694 in 2008 to 4190 in 2014, and arrests 
for driving under the influence of alcohol increased by 181% from 10,409 in 2008 to 29,250 
in 2014 (Arizona Governor’s Office of Highway Safety, 2015). Because we did not have 
access to impaired driver arrest records or crash incident reports for this study, associations 
between enforcement activity and drug-related or alcohol-related crash occurrence could not 
be formally assessed. Surveillance systems that link information from multiple data sources, 
(including driving exposure and citation data, driver drug and alcohol test results, crash 
incident reports, and health care records) would aid in more fully understanding the role of 
substance use in crash occurrence and consequences including injury, disability, and medical 
costs; and better inform injury prevention strategies (Centers for Disease Control and 
Prevention (CDC), 2016).
Two recent evaluations of medical marijuana legalization reported postlaw reductions in 
overall fatal crash rates and attributed the reductions to declines in alcohol-impaired fatal 
crash rates (Anderson et al., 2013; Santaella-Tenorio et al., 2017). In interpreting the 
findings, the authors refer to the substitution hypothesis (Reiman et al., 2017) and suggest 
that declines in alcohol-impaired crash rates might be because some drivers were 
substituting marijuana use for alcohol, thus lowering their crash risk. Our finding of a slight 
but significant increase in the proportion of injured drivers evaluated at Arizona L1TCs who 
tested positive for both marijuana and alcohol after marijuana legalization does not add 
support for this theory. Furthermore, national surveys indicate that 66% of persons who use 
both marijuana and alcohol use the substances simultaneously (Subbaraman and Kerr, 2015). 
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Simultaneous users report consuming both substances more often and driving under the 
influence of alcohol more often than their counterparts who use both substances but not 
simultaneously (Subbaraman and Kerr, 2015).
This study has additional limitations. Because drug or alcohol testing was largely dependent 
on the clinician’s judgement, selection bias was present. The extent and effect of selection 
bias could not be fully examined with available data. As described above, clinicians’ 
decisions to test for drugs might have been impacted by the law change. If a greater 
proportion of untested patients were THC positive in the prelaw period compared to the 
postlaw period, the postlaw trend of THC positivity could be biased upward. A positive THC 
urine screen does not necessarily indicate recent marijuana use; urine screens can remain 
positive without indicating impairment for multiple weeks, particularly among chronic users 
(Lapoint, 2015). Sensitivity and specificity of drug tests performed at the 10 L1TCs are 
unknown and can vary over time and location. The amount of time that elapsed between the 
motor vehicle crash and collection of each injured driver’s BAC is unknown. Therefore, the 
BAC at the time of the crash could have been higher than the BAC recorded in the hospital 
record. In the trend analysis, we did not directly account for factors other than the medical 
marijuana law that might have influenced prevalence of substance-impaired driving and 
crash risk (e.g., the economic recession and recovery, changes in travel patterns, and traffic 
enforcement). In addition, the trend analysis did not incorporate a control condition (e.g., 
examining data from states that had not implemented medical marijuana legislation). Lastly, 
the study findings from Arizona L1TCs might not be generalizable to other hospital settings, 
states, or jurisdictions.
Our study found that overall, the proportion of drivers with BACs above the legal limit was 
twice the proportion of drivers who were marijuana-positive (but not necessarily marijuana-
impaired), indicating that alcohol-impaired driving is a more prevalent threat to road safety 
in Arizona. Strategies exist that can help to identify individuals at risk. For example, 
screening, brief intervention, and referral to treatment (SBIRT) is a proven method to reduce 
morbidity, mortality, and healthcare costs associated with drug and alcohol abuse among 
adults (National Academies of Sciences, 2019). Injured drivers who test positive for drugs or 
alcohol at trauma centers are candidates for SBIRT, especially considering the prevalence of 
high BACs and polysubstance use in this population.
As more states consider legalizing marijuana, further research is needed to clarify the long-
term effects of marijuana legalization (Governors Highway Safety Association, 2017), to 
develop accurate tests to evaluate whether drivers are impaired by marijuana (Governors 
Highway Safety Association, 2017), and to elucidate how marijuana affects the ability to 
drive when used with other substances (Li et al., 2013). Surveillance systems linking driver 
data from multiple other data sources could better inform prevention programs. Finally, 
broader implementation of proven strategies to prevent alcohol-impaired driving (National 
Academies of Sciences, 2019; Centers for Disease Control and Prevention, 2016) and reduce 
recidivism (Voas et al., 2016) could further reduce fatalities on U.S. roads.
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Fig. 1. 
A—Proportion of Injured Drivers Evaluated at Level I Trauma Centers Testing Positive for 
Marijuana — Arizona, 2008–2014 (N = 2590).
B—Proportion of Injured Drivers Evaluated at Level I Trauma Centers Testing Positive for 
Alcohol Above the Legal Limit for their Ageb — Arizona, 2008–2014 (N = 5266).
C—Proportion of Injured Drivers Evaluated at Level I Trauma Centers Testing Positive for 
Marijuana plus Any Alcohol — Arizona, 2008–2014 (N = 1087).
aBlood alcohol concentration limits are > 0 grams per deciliter (g/dL) for drivers aged 16–20 
years and ≥0.08 g/dL for drivers aged ≥ 21 years.
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